Octreotide/midodrine therapy significantly improves survival in type 1 hepatorenal syndrome: Analysis of 53 treated patients & 21 controls

Authors :: Ke-Qin Hu
Namgyal L. Kyulo
Eric Esrailian
Bruce A. Runyon
Eugene R. Pantangco
Source :: Gastroenterology. 124:A718
Publication Year :: 2003
Publisher :: Elsevier BV, 2003.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Midodrine
Gastroenterology
Octreotide
medicine.disease
Endocrinology
Hepatorenal syndrome
Internal medicine
medicine
business
medicine.drug

Tools